Showing posts with label labs. Show all posts
Showing posts with label labs. Show all posts

Monday, June 21, 2021

de Blasio and the EDC are playing down the capability and spread of the Delta Variant

 

Progress New York

 Two days after the de Blasio administration released the findings of its recent weekly COVID-19 variant sequencing study, showing that the prevalence of the dangerous new strain known as the Delta variant had fallen from 8,4 per cent. to 6,7 per cent., a London newspaper, the Financial Times, published a report, estimating the prevalence of the Delta variant in the U.S. at 31 per cent.

For weeks, Progress New York has published reports, which have raised questions about the accuracy of the weekly variant sequencing studies. These reports initially focused on the plunge in the sample size used in the studies. The de Blasio administration responded by changing the presentation of the variant study results. Then, last week, some data was restated almost wholesale.

It is unknown how Mayor Bill de Blasio (WFP-New York City) will explain the divergence in the variant data. The press office supporting Mayor de Blasio refused on Sunday to admit that the administration was presenting unreliable variant study data.

There’s little transparency to the methodology used by the laboratory to sequence the COVID-19 variants.

Many critics are coming to the fore about the de Blasio administration’s lack of transparency about its weekly variant sequencing studies. One critic, known as @BWMosher on the Twitter social media platform, published some analysis of the latest sequencing study, noting some of the restatements to the data underpinning the weekly studies. In that review, it was noted that the laboratory used by the de Blasio administration to conduct the variant studies, the Pandemic Response Lab, was a creation of the City’s controversial arm that intervenes in the free market system to provide subsidies to large corporations.

The lab, also known by the mnemonic “Pearl” for its initials, or PRL, was created in the summer of 2020 by the New York City Economic Development Corporation, or the NYCEDC, first to conduct tests for COVID-19, according to City Hall information. At some point, PRL began to sequence for variants. That the NYCEDC is behind PRL presents a conflict of interest, because the chambres of commerce in New York City have been pressuring Mayor de Blasio to reopen the economy, so that workers can return to office buildings that still remain largely empty. To that end, the titans of industry have been pressuring for the full reopening of public schools from mere months into the pandemic, so that working families could rely on schools as day care. The reliance on public schools as day care for working families was noted in a mid-year budget report issued in 2020 by the Office of the Comptroller of the City of New York Government. “If public schools don’t reopen, parents of up to a million school children will have to provide their own childcare on at least a part-time basis, inhibiting many parents’ ability to return to full-time work,” the report noted.

Were PRL to report prevalence rates for the Delta variant that mirrored the Financial Times model, then businesses, office buildings, and public schools would face pressure to delay, or cancel, their reopenings. It is not known whether the unreliable sequencing data is a result of the appearance of a conflict of interest for the NYCEDC.

 

Wednesday, June 9, 2021

Droppin' a half a billion on science

https://external-content.duckduckgo.com/iu/?u=https%3A%2F%2Fs.abcnews.com%2Fimages%2FTechnology%2FWireAP_9bf8b23a8fe347f38a157e172696df12_16x9_992.jpg&f=1&nofb=1

 AMNY

 Mayor Bill de Blasio announced that the city will invest another $500 million into the life sciences industry, doubling down on its initial investment back in 2016.

The combined billion-dollar bet is part of de Blasio’s plan to make New York City the public health capital of the world. The original investment helped create labs at academic institutions, funded paid internships, and created over 2 million square feet of new life science space. The additional investment will help to spur on that growth. 

De Blasio likened the investments into the life sciences industry to how the five boroughs grew its tech industry.

“We need to build up life sciences, this is the future,” said de Blasio. “This is what’s going to make New York city great going forward.”

De Blasio says the investments into life sciences will allow for the space and opportunity to create innovations for the future. He frequently mentioned the city’s effort during the height of the COVID-19 pandemic last year, as evidence that the life sciences industry is crucial to the city’s growth and future. 

“We have the talent base, we have the hospitals, the universities, we have the ability to do the research that could blow away the capacity of any other part of the country,” said de Blasio.

The expanded initiative is expected to create 40,000 jobs. The city will provide up to $112 million in capital to award $20 million to support one or more innovation projects.

Multiple awardees can access up to $20 million each.

I don't know what "life sciences" is supposed to mean but I know the city better not give a contract to Ecohealth.